| Dr Mirza Mujadil Ahmad, MD | |
|
1000 1st Dr Nw, Austin, MN 55912-2941 | |
| (507) 433-7351 | |
| Not Available |
| Full Name | Dr Mirza Mujadil Ahmad |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 1000 1st Dr Nw, Austin, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1568968444 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 70217 (Minnesota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| District One Hospital | Faribault, MN | Hospital |
| St Francis Regional Medical Center | Shakopee, MN | Hospital |
| North Memorial Health | Robbinsdale, MN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allina Health System | 4587573613 | 3071 |
News Archive
The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses, First Lady of Rwanda Jeannette Kagame and CEO of Access Bank Plc Aigboje Aig-Imoukhuede, who both serve on the Friends of the Global Fund Africa board, write together in a East African opinion piece that calls upon the private sector to help bolster the work with African governments to improve health outcomes in Africa.
Opioid misuse has become a significant public health problem. Despite efforts to control its use, opioid is still the most widely prescribed class of medicines. Now, a new study shows that when adults mix prescription opioids for pain with marijuana or cannabis, they report higher rates of anxiety and depression symptoms.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present at the Cell & Gene Therapy Forum 2015, January 26 - 28, 2015 at Grand Hayatt in Washington DC, United States.
A cancer research specialist from the University of the West of England, Bristol is one of a panel of international experts who have had a report published in the Journal of Clinical Oncology today that gives new global guidelines for testing regimes for breast cancer patients. The guidelines relate to cancer patients with oestrogen and progesterone receptor positive breast tumours.
› Verified 7 days ago
| Entity Name | Allina Health System |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295272342 PECOS PAC ID: 4587573613 Enrollment ID: O20040319000460 |
News Archive
The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses, First Lady of Rwanda Jeannette Kagame and CEO of Access Bank Plc Aigboje Aig-Imoukhuede, who both serve on the Friends of the Global Fund Africa board, write together in a East African opinion piece that calls upon the private sector to help bolster the work with African governments to improve health outcomes in Africa.
Opioid misuse has become a significant public health problem. Despite efforts to control its use, opioid is still the most widely prescribed class of medicines. Now, a new study shows that when adults mix prescription opioids for pain with marijuana or cannabis, they report higher rates of anxiety and depression symptoms.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present at the Cell & Gene Therapy Forum 2015, January 26 - 28, 2015 at Grand Hayatt in Washington DC, United States.
A cancer research specialist from the University of the West of England, Bristol is one of a panel of international experts who have had a report published in the Journal of Clinical Oncology today that gives new global guidelines for testing regimes for breast cancer patients. The guidelines relate to cancer patients with oestrogen and progesterone receptor positive breast tumours.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mirza Mujadil Ahmad, MD 1000 1st Dr Nw, Austin, MN 55912-2941 Ph: () - | Dr Mirza Mujadil Ahmad, MD 1000 1st Dr Nw, Austin, MN 55912-2941 Ph: (507) 433-7351 |
News Archive
The serious health problems afflicting our continent significantly affect our economies, reducing productivity, creating gaps in the workforce, causing innumerable sick days and restricting growth in African businesses, First Lady of Rwanda Jeannette Kagame and CEO of Access Bank Plc Aigboje Aig-Imoukhuede, who both serve on the Friends of the Global Fund Africa board, write together in a East African opinion piece that calls upon the private sector to help bolster the work with African governments to improve health outcomes in Africa.
Opioid misuse has become a significant public health problem. Despite efforts to control its use, opioid is still the most widely prescribed class of medicines. Now, a new study shows that when adults mix prescription opioids for pain with marijuana or cannabis, they report higher rates of anxiety and depression symptoms.
CytRx Corporation (NASDAQ:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received approval from the U.S. Food and Drug Administration (FDA) to continue dosing patients with aldoxorubicin until disease progression in a planned pivotal, global Phase 3 clinical trial with aldoxorubicin as a second-line treatment for soft tissue sarcomas.
TxCell SA, a biotechnology company developing innovative, cost-effective, personalized T cell immunotherapies using antigen specific regulatory T-cells (Ag-Tregs) for severe chronic inflammatory and autoimmune diseases, announces today that Dr. Miguel Forte, Sr. VP Clinical Development and Regulatory Affairs, TxCell, will present at the Cell & Gene Therapy Forum 2015, January 26 - 28, 2015 at Grand Hayatt in Washington DC, United States.
A cancer research specialist from the University of the West of England, Bristol is one of a panel of international experts who have had a report published in the Journal of Clinical Oncology today that gives new global guidelines for testing regimes for breast cancer patients. The guidelines relate to cancer patients with oestrogen and progesterone receptor positive breast tumours.
› Verified 7 days ago
Izza Mir, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 | |
Cynthia Marie Dube, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-434-1092 Fax: 507-434-1477 | |
Saba Rahman, Internal Medicine Medicare: Medicare Enrolled Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 | |
Mohammed Yousufuddin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 | |
Dr. James Michael Bisanti, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 | |
Dr. Manal Bakhiet, MBBS Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 | |
Lawrence Ray Keenan, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1000 1st Dr Nw, Austin, MN 55912 Phone: 507-433-7351 |